Research ExplorerJournalsEUR NEUROPSYCHOPHARM Publications

EUR NEUROPSYCHOPHARM - European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

1 - 27 out of 27Page size: 50

Publications

  1. 2024

  2. Young people at risk for developing bipolar disorder: Two-year findings from the multicenter prospective, naturalistic Early-BipoLife study

    Martini, J., Bröckel, K. L., Leopold, K., Berndt, C., Sauer, C., Maicher, B., Juckel, G., Krüger-Özgürdal, S., Fallgatter, A. J., Lambert, M., Bechdolf, A., Reif, A., Matura, S., Biere, S., Kittel-Schneider, S., Stamm, T., Bermpohl, F., Kircher, T., Falkenberg, I., Jansen, A., Dannlowski, U., Correll, C. U., Fusar-Poli, P., Hempel, L. M., Mikolas, P., Ritter, P., Bauer, M. & Pfennig, A., 01.2024, In: EUR NEUROPSYCHOPHARM. 78, p. 43-53 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. 2023

  4. Associations between individual depressive symptoms and immunometabolic characteristics in major depression

    Chae, W. R., Baumert, J., Nübel, J., Brasanac, J., Gold, S. M., Hapke, U. & Otte, C., 06.2023, In: EUR NEUROPSYCHOPHARM. 71, p. 25-40 16 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. 2022

  6. Erratum to "Digital tools for the assessment of pharmacological treatment for depressive disorder: State of the Art. [European Neuropsychopharmacology 60 (2022) 100-116]"

    Van Assche, E., Ramos-Quiroga, J. A., Pariante, C. M., Sforzini, L., Young, A. H., Flossbach, Y., Gold, S. M., Hoogendijk, W. J. G., Baune, B. T. & Maron, E., 10.2022, In: EUR NEUROPSYCHOPHARM. 63, p. 4-5 2 p.

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  7. 2021

  8. MMP9 mRNA is a potential diagnostic and treatment monitoring marker for PTSD: Evidence from mice and humans

    Chevalier, C. M., Krampert, L., Schreckenbach, M., Schubert, C. F., Reich, J., Novak, B., Schmidt, M. V., Rutten, B. P. F. & Schmidt, U., 10.2021, In: EUR NEUROPSYCHOPHARM. 51, p. 20-32 13 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. Neuroimaging evidence for structural correlates in adolescents resilient to polysubstance use: A five-year follow-up study

    Filippi, I., Galinowski, A., Lemaître, H., Massot, C., Zille, P., Frère, P., Miranda-Marcos, R., Trichard, C., Guldner, S., Vulser, H., Paillère-Martinot, M-L., Quinlan, E. B., Desrivieres, S., Gowland, P., Bokde, A., Garavan, H., Heinz, A., Walter, H., Daedelow, L., Büchel, C., Bromberg, U., Conrod, P. J., Flor, H., Banaschewski, T., Nees, F., Heintz, S., Smolka, M., Vetter, N. C., Papadopoulos-Orfanos, D., Whelan, R., Poustka, L., Paus, T., Schumann, G., Artiges, E., Martinot, J-L. & IMAGEN Consortium, 08.2021, In: EUR NEUROPSYCHOPHARM. 49, p. 11-22 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. Therapygenetic effects of 5-HTTLPR on cognitive-behavioral therapy in anxiety disorders: A meta-analysis

    Schiele, M. A., Reif, A., Lin, J., Alpers, G. W., Andersson, E., Andersson, G., Arolt, V., Bergström, J., Carlbring, P., Eley, T. C., Esquivel, G., Furmark, T., Gerlach, A. L., Hamm, A., Helbig-Lang, S., Hudson, J. L., Lang, T., Lester, K. J., Lindefors, N., Lonsdorf, T. B., Pauli, P., Richter, J., Rief, W., Roberts, S., Rück, C., Schruers, K. R. J., Thiel, C., Wittchen, H-U., Domschke, K., Weber, H. & Lueken, U., 03.2021, In: EUR NEUROPSYCHOPHARM. 44, p. 105-120 16 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. Noradrenergic stimulation increases fear memory expression

    Kausche, F. M., Zerbes, G., Kampermann, L., Müller, J. C., Wiedemann, K., Büchel, C. & Schwabe, L., 02.2021, In: EUR NEUROPSYCHOPHARM. 43, p. 71-81 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. The "VIP-ADHD trial": Does brain arousal have prognostic value for predicting response to psychostimulants in adult ADHD patients?

    Strauß, M., Petroff, D., Huang, J., Ulke, C., Paucke, M., Bogatsch, H., Böhme, P., Hoffmann, K., Reif, A., Kittel-Schneider, S., Heuser, I., Ahlers, E., Gallinat, J., Schöttle, D., Fallgatter, A., Ethofer, T., Unterecker, S. & Hegerl, U., 02.2021, In: EUR NEUROPSYCHOPHARM. 43, p. 116-128 13 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. 2020

  14. Region-specific effects of acute haloperidol in the human midbrain, striatum and cortex

    Wächtler, C. O., Chakroun, K., Clos, M., Bayer, J., Hennies, N., Beaulieu, J. M. & Sommer, T., 06.2020, In: EUR NEUROPSYCHOPHARM. 35, p. 126-135 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. 2018

  16. A neurobiological pathway to smoking in adolescence: TTC12-ANKK1-DRD2 variants and reward response

    Macare, C., Ducci, F., Zhang, Y., Ruggeri, B., Jia, T., Kaakinen, M., Kalsi, G., Charoen, P., Casoni, F., Peters, J., Bromberg, U., Hill, M., Buxton, J., Blakemore, A., Veijola, J., Büchel, C., Banaschewski, T., Bokde, A. L. W., Conrod, P., Flor, H., Frouin, V., Gallinat, J., Garavan, H., Gowland, P. A., Heinz, A., Ittermann, B., Lathrop, M., Martinot, J-L., Paus, T., Desrivières, S., Munafò, M., Järvelin, M-R., Schumann, G. & IMAGEN Consortium, 10.2018, In: EUR NEUROPSYCHOPHARM. 28, 10, p. 1103-1114 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. WITHDRAWN: P.2.002 Glutamatergic dysfunction within neonatal prefrontal circuitry in a genetic-environmental model of mental disorders

    Chinin, M., Lindemann, C., Pöpplau, J. A., Xu, X., Ahlbeck, J., Bitzenhofer, S. H. & Hanganu-Opatz, I. L., 03.2018, In: EUR NEUROPSYCHOPHARM. 28 Suppl 1, p. S22

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. 2016

  19. Replication of the association between CHRNA4 rs1044396 and harm avoidance in a large population-based sample

    Bey, K., Lennertz, L., Markett, S., Petrovsky, N., Gallinat, J., Gründer, G., Spreckelmeyer, K. N., Wienker, T. F., Mobascher, A., Dahmen, N., Thuerauf, N., Kornhuber, J., Kiefer, F., Toliat, M. R., Nürnberg, P., Winterer, G. & Wagner, M., 01.01.2016, In: EUR NEUROPSYCHOPHARM. 26, 1, p. 150-5

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. 2015

  21. Effects of post-extinction l-DOPA administration on the spontaneous recovery and reinstatement of fear in a human fMRI study

    Haaker, J., Lonsdorf, T. B. & Kalisch, R., 10.2015, In: EUR NEUROPSYCHOPHARM. 25, 10, p. 1544-55 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. Cross-sex hormone treatment in male-to-female transsexual persons reduces serum brain-derived neurotrophic factor (BDNF)

    Fuß, J., Hellweg, R., Van Caenegem, E., Briken, P., Stalla, G. K., T'Sjoen, G. & Auer, M. K., 01.2015, In: EUR NEUROPSYCHOPHARM. 25, 1, p. 95-99

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. 2014

  24. Nonadherence to antipsychotics: the role of positive attitudes towards positive symptoms

    Moritz, S., Hünsche, A. & Lincoln, T. M., 01.11.2014, In: EUR NEUROPSYCHOPHARM. 24, 11, p. 1745-1752 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. Long-term escitalopram blunts autonomic reactivity to pharmacological panic challenge in healthy men

    Agorastos, A., Kellner, M., Stiedl, O., Muhtz, C., Wiedemann, K. & Demiralay, C., 2014, In: EUR NEUROPSYCHOPHARM. 24, Suppl 2, p. S173

    Research output: SCORING: Contribution to journal › Conference abstract in journal › Research › peer-review

  26. The 5-HTTLPR genotype modulates heart rate variability and reactivity after pharmacological panic challenge in healthy men

    Agorastos, A., Kellner, M., Stiedl, O., Muhtz, C., Wiedemann, K. & Demiralay, C., 2014, In: EUR NEUROPSYCHOPHARM. 24, Suppl 2, p. 172

    Research output: SCORING: Contribution to journal › Conference abstract in journal › Research › peer-review

  27. The cumulative effect of childhood trauma on adult mental and physical health: results from the Marine Resiliency Study

    Agorastos, A., Pittman, J. O. E., Angkaw, A. C., Nievergelt, C. M., Parisi, S. A., Barkauskas, D. A. & Baker, D. G., 2014, In: EUR NEUROPSYCHOPHARM. 24, Suppl 2, p. S619

    Research output: SCORING: Contribution to journal › Conference abstract in journal › Research › peer-review

  28. 2013

  29. Subjective well-being in schizophrenia: a randomised controlled open-label 12-month non-inferiority study comparing quetiapine XR with risperidone (RECOVER)

    Naber, D., Peuskens, J., Schwarzmann, N., Goltz, M., Krüger, H., Lambert, M. & Haro, J. M., 01.10.2013, In: EUR NEUROPSYCHOPHARM. 23, 10, p. 1257-69 13 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. Impact of safety warnings on antipsychotic prescriptions in dementia: nothing has changed but the years and the substances

    Schulze, J., van den Bussche, H., Glaeske, G., Kaduszkiewicz, H., Wiese, B. & Hoffmann, F., 01.09.2013, In: EUR NEUROPSYCHOPHARM. 23, 9, p. 1034-42 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. 2010

  32. Suicide attempts in a prospective cohort of patients with schizophrenia treated with sertindole or risperidone.

    Crocq, M. A., Naber, D., Lader, M. H., Thibaut, F., Drici, M., Everitt, B., Hall, G. C., Le Jeunne, C., Mittoux, A., Peuskens, J., Priori, S., Sturkenboom, M., Thomas, S. H. L., Tanghøj, P., Toumi, M., Mann, R. & Moore, N. D., 2010, In: EUR NEUROPSYCHOPHARM. 20, 12, p. 829-838 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. 2009

  34. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.

    Goodwin, G., Fleischhacker, W., Arango, C., Baumann, P., Davidson, M., de Hert, M., Falkai, P., Kapur, S., Leucht, S., Licht, R., Naber, D., O'Keane, V., Papakostas, G., Vieta, E. & Zohar, J., 2009, In: EUR NEUROPSYCHOPHARM. 19, 7, p. 520-532 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. 2007

  36. Three-year antipsychotic effectiveness in the outpatient care of schizophrenia: observational versus randomized studies results.

    Haro, J. M., Suarez, D., Novick, D., Brown, J., Usall, J. & Naber, D., 2007, In: EUR NEUROPSYCHOPHARM. 17, 4, p. 235-244 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. 2004

  38. Overnight metyrapone and combined dexamethasone/metyrapone tests in post-traumatic stress disorder: preliminary findings.

    Kellner, M., Otte, C., Yassouridis, A., Schick, M., Jahn, H. & Wiedemann, K., 2004, In: EUR NEUROPSYCHOPHARM. 14, 4, p. 337-339 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. Tools for measuring clinical effectiveness.

    Naber, D. & Vita, A., 2004, In: EUR NEUROPSYCHOPHARM. 14, 4, p. 435-444 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. 2001

  41. Good tolerability equals good results: the patient's perspective.

    Naber, D. & Karow, A., 2001, In: EUR NEUROPSYCHOPHARM. 11, 4, p. 391-396 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  42. 1996

  43. Flumazenil attenuates the pituitary response to CRH in healthy males.

    Ströhle, A. & Wiedemann, K., 1996, In: EUR NEUROPSYCHOPHARM. 6, 4, p. 323-325 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review